Get to know ZILBRYSQ

A targeted, self-administered treatment for adults with anti-AChR antibody-positive generalized myasthenia gravis (gMG)


For more information about ZILBRYSQ, sign up for email updates

Once you sign up, you can look forward to educational resources, treatment support, and tools designed to help you talk to your doctor about ZILBRYSQ.

All fields are required.

I am 18 years of age or older.

By providing your information on this webpage, you acknowledge you are a US resident and give UCB and its business partners permission to send you information or contact you and/or your healthcare provider regarding your disease, as well as information on other related treatments, products, and services, and for marketing and informational purposes by email or postal mail.

At any time, you may unsubscribe and remove yourself from the mailing list. Please review the Privacy Policy.

Complete Terms of Use.